Here is the text under discussion (sccr/32/3)
III. RIGHTS TO BE GRANTED/PROTECTION
(1) Alternative A
(i) Broadcasting organizations shall have the right to authorize or prohibit the [simultaneous,
near-simultaneous] [and deferred] retransmission of their programme-carrying signal to the
public [[by any means] [/over any medium].
Continue Reading
Highlights of the discussion regarding transmission over computer network based on the second non paper (proposal by Japan)
I have received a request from KEI and I am ready to listen to their contributions at this point. KEI has the floor.
>> EIFL.NET: I will start with retracted and withdrawn works. So libraries and archives have a mandate to pre seven public record for the future. In the analog aenvironment exhaustion to the distribution right provides legal means to insure its… Continue Reading
In the run up to the 69th World Health Assembly, to be convened in Geneva from 23 May 2016 to 28 May 2016, the World Health Organization (WHO) has prepared a document (A69/INF./3, 13 May 2016) entitled Voluntary contributions by fund and by contributor, 2015. Total voluntary contributions to WHO in 2015 amounted to $1,836,970,206 which represented a dip from the 2014 figure of $2,001,713,247.
(More on Colombia here: /colombia)
Continue Reading
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On April 22nd, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Dedalus… Continue Reading
On April 26, 2016, Congressman Lloyd Doggett (D-Texas) delivered the keynote address at a panel discussion on drug pricing at the Center for American Progress, where he addressed the Federal government’s role in subsidizing drug development, ensuring affordable access at reasonable prices for U.S. citizens, industry practices related to monopoly pricing, and legislative solutions to promote rational and affordable drug prices.
2016:1 KEI Briefing Note
Transparency of Patent Landscapes
April 25, 2016
At an April 12, 2016 WIPO seminar, Reed F. Beall and Amir Attaran presented a paper, “Patent-based Analysis of the World Health Organization’s 2013 Model List of Essential Medicines,” which includes the following odd comment:
